CLEAR: (CLozapine in EARly psychosis) A Multi-Centre, Randomised Controlled trial of Clozapine for Young People with Treatment Resistant Psychosis in Real World Settings

Broome, Matthew (Co-Investigator)
Upthegrove, Rachel (Principal Investigator)

Short title	CLEAR: (CLozapine in EARly psychosis) A Multi-Centre, Randomised Controlled trial of Clozapine for Young People with Treatment Resistant Psychosis in Real World Settings
Status	Active
Effective start/end date	1/09/21 → 28/02/27

Funding

NIHR

1 Article

CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings
Casetta, C., Santosh, P., Bayley, R., Bisson, J., Byford, S., Dixon, C., Drake, R. J., Elvins, R., Emsley, R., Fung, N., Hayes, D., Howes, O., James, A., James, K., Jones, R., Killaspy, H., Lennox, B., Marchant, L., McGuire, P., Oloyede, E., & 5 othersRogdaki, M., Upthegrove, R., Walters, J., Egerton, A. & MacCabe, J. H., 14 Feb 2024, In: BMC Psychiatry. 24, 1, 13 p., 122.
Research output: Contribution to journal › Article › peer-review

Open Access
File